MIST
Price
$2.04
Change
-$0.02 (-0.97%)
Updated
Feb 21 closing price
Capitalization
108.79M
37 days until earnings call
MLTX
Price
$42.33
Change
+$0.23 (+0.55%)
Updated
Feb 21 closing price
Capitalization
2.67B
29 days until earnings call
Ad is loading...

MIST vs MLTX

Header iconMIST vs MLTX Comparison
Open Charts MIST vs MLTXBanner chart's image
Milestone Pharmaceuticals
Price$2.04
Change-$0.02 (-0.97%)
Volume$568.51K
Capitalization108.79M
MoonLake Immunotherapeutics
Price$42.33
Change+$0.23 (+0.55%)
Volume$225.28K
Capitalization2.67B
MIST vs MLTX Comparison Chart
Loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MIST vs. MLTX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIST is a Hold and MLTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (MIST: $2.04 vs. MLTX: $42.33)
Brand notoriety: MIST and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MIST: 76% vs. MLTX: 59%
Market capitalization -- MIST: $108.79M vs. MLTX: $2.67B
MIST [@Biotechnology] is valued at $108.79M. MLTX’s [@Biotechnology] market capitalization is $2.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MIST’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • MIST’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MIST is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MIST’s TA Score shows that 1 TA indicator(s) are bullish while MLTX’s TA Score has 3 bullish TA indicator(s).

  • MIST’s TA Score: 1 bullish, 6 bearish.
  • MLTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than MIST.

Price Growth

MIST (@Biotechnology) experienced а -10.13% price change this week, while MLTX (@Biotechnology) price change was -2.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

MIST is expected to report earnings on May 19, 2025.

MLTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.67B) has a higher market cap than MIST($109M). MIST YTD gains are higher at: -13.559 vs. MLTX (-21.828). MIST has higher annual earnings (EBITDA): -39.14M vs. MLTX (-108.45M). MLTX has more cash in the bank: 494M vs. MIST (76.4M). MLTX has less debt than MIST: MLTX (3.69M) vs MIST (54M). MIST (0) and MLTX (0) have equivalent revenues.
MISTMLTXMIST / MLTX
Capitalization109M2.67B4%
EBITDA-39.14M-108.45M36%
Gain YTD-13.559-21.82862%
P/E RatioN/AN/A-
Revenue00-
Total Cash76.4M494M15%
Total Debt54M3.69M1,464%
TECHNICAL ANALYSIS
Technical Analysis
MISTMLTX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Ad is loading...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHAIX16.24N/A
N/A
Chase Growth Institutional
TSRLX74.43N/A
N/A
Touchstone Large Cap Focused R6
IVOAX18.61-0.19
-1.01%
Macquarie Mid Cap Income Opps A
FSWFX67.72-1.54
-2.22%
American Funds SMALLCAP World 529-F-2
STSRX14.85-0.39
-2.56%
American Beacon Stephens Sm Cp Gr R6

MIST and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIST has been loosely correlated with CLDX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MIST jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
-0.97%
CLDX - MIST
39%
Loosely correlated
-0.58%
KRYS - MIST
36%
Loosely correlated
+2.87%
MLTX - MIST
36%
Loosely correlated
+0.55%
RGNX - MIST
30%
Poorly correlated
-1.22%
GYRE - MIST
28%
Poorly correlated
-8.12%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.55%
XENE - MLTX
37%
Loosely correlated
+0.89%
AKBA - MLTX
37%
Loosely correlated
-5.76%
CRNX - MLTX
36%
Loosely correlated
+1.63%
ATXS - MLTX
36%
Loosely correlated
-0.15%
MIST - MLTX
36%
Loosely correlated
-0.97%
More